Aibotics Inc.
AIBT
Other OTC0.00
USD
+0.00
- -
CIK
0001763329
ISIN
US62846W1071
CUSIP
62846W107
Return %
Stock
S&P500
1Y
-93.75
18.46
3Y
-97.83
64.72
5Y
-99.98
72.79
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Benjamin Kaplan
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 100 SE 2nd Street Miami FL United States of America 33131
- IPO Date
- Mar 31, 2006
- CIK
- 0001763329
- Website
- aibotics.ai
- Similar Companies
- Business
- Aibotics Inc. engages in AI-driven robotics and automation solutions focused on transforming industrial, service and hospitality operations through advanced machine learning and robotics platforms. The company develops autonomous and semi-autonomous robotic systems, AI software, and integrated IoT solutions designed to optimize workflows, reduce labor costs, and improve accuracy across multiple sectors. Headquartered in Miami, Florida, Aibotics operates internationally with strategic partnerships and distribution agreements to extend its reach into key markets in the Middle East, the Caribbean and beyond. Founded in 2025, the company emphasizes scalable, end-to-end automation offerings tailored to manufacturing, logistics, retail, healthcare and hospitality customers. Core products and services include AI-enabled service robots and automation platforms; robot hardware integrated with cloud-based AI software; deployment and commissioning services; system integration; remote monitoring and predictive maintenance; and ongoing support, training, and customization. Recent developments include strategic alliances to accelerate international expansion, multi-year distribution partnerships, and new product introductions expanding the flagship robot and automation portfolio across additional verticals and regions. Subsidiaries and affiliate arrangements support regional deployments, local service capabilities, and localized regulatory compliance, reinforcing Aibotics’ stance as a global provider of AI-powered robotic solutions.
Mycotopia Therapies Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBT
AIBotics Provides 2025 Update; Strengthens Position in AI, Wellness, and Robotics
Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions